Faculty Opinions recommendation of Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).
2018 ◽
Vol 14
(3)
◽
pp. 233-238
◽
2021 ◽
Vol 37
(4)
◽
pp. 635-642
2015 ◽
Vol 45
(8)
◽
pp. 774-779
◽